Mimedx Group Stock Today
| MDXG Stock | USD 6.33 0.10 1.61% |
Performance0 of 100
| Odds Of DistressLess than 1
|
MiMedx is trading at 6.33 as of the 19th of April 2024. This is a 1.61 percent up since the beginning of the trading day. The stock's lowest day price was 6.2. MiMedx has a very small chance of experiencing financial distress in the next few years, but has generated negative returns over the last 90 days. Equity ratings for MiMedx Group are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 25th of April 2023 and ending today, the 19th of April 2024. Click here to learn more.
Business Domain Pharmaceuticals, Biotechnology & Life Sciences | IPO Date 22nd of August 2007 | Category Healthcare | Classification Health Care |
MiMedx Group, Inc. develops and distributes placental tissue allografts for various sectors of healthcare. The company sells its products through direct sales force and independent sales agents, as well as through independent distributors primarily in the United States. The company has 146.96 M outstanding shares of which 5.18 M shares are now shorted by private and institutional investors with about 5.18 trading days to cover. More on MiMedx Group
Moving together with MiMedx Stock
| 0.88 | JNJ | Johnson Johnson Financial Report 18th of July 2024 | PairCorr |
| 0.61 | PFE | Pfizer Inc Sell-off Trend | PairCorr |
Moving against MiMedx Stock
| 0.64 | NUVB | Nuvation Bio Financial Report 2nd of May 2024 | PairCorr |
Follow Valuation Options Odds of Bankruptcy
Financial Report 7th of May 2024
MiMedx Stock Highlights
Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. MiMedx's investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding MiMedx or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
| CEO Director | Joseph Capper | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Business Concentration | Biotechnology, Pharmaceuticals, Biotechnology & Life Sciences, Health Care, NASDAQ Composite, NASDAQ Composite Total, NASDAQ Health Care, Health Care, Biotechnology, Biotechnology, Healthcare (View all Sectors) | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Average Analyst Recommendation Analysts covering MiMedx report their recommendations after researching MiMedx's financial statements, talking to executives and customers, or listening in on MiMedx's conference calls. The current trade recommendation is based on an ongoing consensus estimate among financial analysts covering MiMedx Group. The MiMedx consensus assessment is calculated by taking the average forecast from all of the analysts covering MiMedx. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Financial Strength Based on the key measurements obtained from MiMedx's financial statements, MiMedx Group is performing exceptionally good at this time. It has a great odds to report excellent financial results in May. Financial strength of MiMedx Group is based on its profitability, leverage, liquidity, source of funds, and operating efficiency.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
MiMedx's financial strength is of vital concern to both outside investors and internal stakeholders. Efficiency and cost control are keys to MiMedx's success, along with its ability to generate sufficient cash flow to pay bills, repay debt, and make a consistent year-to-year profit. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Financial leverage usually refers to the use of borrowed funds to amplify returns from an investment. In general, analyzing the relationship between debt to total assets helps investors to understand MiMedx's financial leverage. It provides some insight into what part of MiMedx's total assets is financed by creditors.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
MiMedx Group (MDXG) is traded on NASDAQ Exchange in USA. It is located in 1775 West Oak Commons Court, NE, Marietta, GA, United States, 30062 and employs 895 people. MiMedx is listed under Biotechnology category by Fama And French industry classification. The company currently falls under 'Small-Cap' category with a current market capitalization of 915.55 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate MiMedx's market, we take the total number of its shares issued and multiply it by MiMedx's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. MiMedx Group conducts business under Biotechnology sector and is part of Health Care industry. The entity has 146.96 M outstanding shares of which 5.18 M shares are now shorted by private and institutional investors with about 5.18 trading days to cover.
MiMedx Group currently holds about 72.5 M in cash with 26.77 M of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.64.
Check MiMedx Probability Of Bankruptcy
Ownership AllocationMiMedx Group maintains a total of 146.96 Million outstanding shares. Over half of MiMedx's outstanding shares are owned by institutional investors. These institutional investors are typically referred to as corporate investors that shop for positions in a given instrument to benefit from reduced trade commissions. Consequently, these institutions are subject to different rules and regulations than regular investors in MiMedx Group. Please watch out for any change in the institutional holdings of MiMedx Group as this could mean something significant has changed or is about to change at the company. Please note that no matter how many assets the company has, if the real value of the firm is less than the current market value, you may not be able to make money on it.
Check MiMedx Ownership Details
MiMedx Stock Price Odds Analysis
In reference to a normal probability distribution, the odds of MiMedx jumping above the current price in 90 days from now is close to 99%. The MiMedx Group probability density function shows the probability of MiMedx stock to fall within a particular range of prices over 90 days. Given the investment horizon of 90 days MiMedx Group has a beta of -0.2419. This indicates as returns on the benchmark increase, returns on holding MiMedx are expected to decrease at a much lower rate. During a bear market, however, MiMedx Group is likely to outperform the market. Additionally, miMedx Group has a negative alpha, implying that the risk taken by holding this instrument is not justified. The company is significantly underperforming the NYSE Composite.
Based on a normal probability distribution, the odds of MiMedx to move above the current price in 90 days from now is close to 99 (This MiMedx Group probability density function shows the probability of MiMedx Stock to fall within a particular range of prices over 90 days) .
MiMedx Stock Institutional Holders
Institutional Holdings refers to the ownership stake in MiMedx that is held by large financial organizations, pension funds or endowments. Institutions may purchase large blocks of MiMedx's outstanding shares and can exert considerable influence upon its management. Institutional holders may also work to push the share price higher once they own the stock. Extensive social media coverage, TV shows, articles in high-profile magazines, and presentations at investor conferences help move the stock higher, increasing MiMedx's value.| Instituion | Recorded On | Shares | |
| Charles Schwab Investment Management Inc | 2023-12-31 | 1.1 M | |
| Royal Bank Of Canada | 2023-12-31 | 1.1 M | |
| Northern Trust Corp | 2023-12-31 | 1.1 M | |
| Goldman Sachs Group Inc | 2023-12-31 | 970.5 K | |
| Prudential Financial Inc | 2023-12-31 | 938 K | |
| Arrowstreet Capital Limited Partnership | 2023-12-31 | 922.6 K | |
| Kanen Wealth Management Llc | 2023-09-30 | 922.5 K | |
| Royce & Associates, Lp | 2023-12-31 | 862.5 K | |
| Federated Hermes Inc | 2023-12-31 | 807.4 K | |
| Essex Woodlands Health Ventures | 2023-12-31 | 28.2 M | |
| Blackrock Inc | 2023-12-31 | 9.5 M |
MiMedx Historical Income Statement
MiMedx Group Income Statement is one of the three primary financial statements used for reporting MiMedx's overall financial performance over a current year or for a given accounting period. An Income Statement sometimes referred to as the statement of MiMedx Group revenue and expense. MiMedx Income Statement primarily focuses on the company's revenues and expenses during a particular period.
At this time, MiMedx's Operating Income is most likely to increase significantly in the upcoming years. The MiMedx's current EBIT is estimated to increase to about 38.9 M, while Other Operating Expenses is projected to decrease to roughly 169.4 M. View More FundamentalsMiMedx Stock Against Markets
Picking the right benchmark for MiMedx stock is fundamental to making educated investment choices. Many naive investors compare their positions with the S&P 500 or with the Nasdaq. But these benchmarks are not all-inclusive and generally should be used only for large-capitalization equities or stock offerings from large companies. When the price of a selected benchmark declines in a down market, there may be an uptick in MiMedx stock price where buyers come in believing the asset is cheap. The opposite is true when the market is bullish; so, accurately picking the benchmark for MiMedx is critical whether you are bullish or bearish towards MiMedx Group at a given time. Please also check how MiMedx's historical prices are related to one of the top price index indicators.
Be your own money manager
Our tools can tell you how much better you can do entering a position in MiMedx without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Stocks Directory Now
Stocks DirectoryFind actively traded stocks across global markets |
| All Next | Launch Module |
MiMedx Corporate Directors
MiMedx corporate directors refer to members of a MiMedx board of directors. The board of directors generally takes responsibility for the MiMedx's affairs and long-term direction of the entity. A corporate director does not make decisions for the corporation on his own. As a member of the board of directors, she or he must function as a part of a group that makes decisions on behalf of the business only by the board of directors' meetings. To pass a resolution, a majority of MiMedx's board members must vote for the resolution. The MiMedx board of directors' duties also include the election, removal, and supervision of officers, including the adoption, amendment, and repeal of bylaws.| Bruce Hack | Independent Director | Profile | |
| Joseph Bleser | Independent Director | Profile | |
| Larry Papasan | Independent Director | Profile | |
| Richard Barry | Director | Profile |
How to buy MiMedx Stock?
Before investing in MiMedx, you must ensure you fully understand your financial goals and how diversified (or not) your overall investments are now. Then, after you clearly understand your investment objectives, consider investing in MiMedx. To buy MiMedx stock, you can follow these steps:- Choose a brokerage firm: You need to select a brokerage firm to buy shares of MiMedx. Some popular options include Charles Schwab, Fidelity, TD Ameritrade, and Robinhood.
- Open an account: Once you have chosen a brokerage firm, you will need to open an account. You will be required to provide personal information, such as your name, address, and Social Security number.
- Fund your account: You will need to deposit funds into your brokerage account to purchase MiMedx stock. You can do this by transferring funds from your bank account or other investment accounts.
- Place your order: Once you have located MiMedx Group stock in your brokerage account, you can place your order to buy it. You will need to specify the number of shares you want to buy and the price you are willing to pay.
- Monitor your investment: After you have purchased MiMedx Group stock, you should monitor your investment to track its performance and make informed decisions about buying, selling, or holding the stock
It's important to note that investing in stocks, such as MiMedx Group, carries risks, and you should carefully consider your investment goals and risk tolerance before making any investment decisions. Also, remember various factors, including economic indicators, change in net worth, political events, company-specific news, and investor sentiment, can influence the stock market. These factors can cause fluctuations in stock prices and lead to market volatility affecting your buy or sell decision. However, volatility can also present opportunities for investors to make gains by buying stocks when prices are low and selling when they are high. It's important for investors to have a long-term perspective and a well-diversified portfolio to manage the impact of stock market volatility on their investments. For more information on how to buy MiMedx Stock please use our How to Invest in MiMedx guide.
Already Invested in MiMedx Group?
The danger of trading MiMedx Group is mainly related to its market volatility and Company specific events. As an investor, you must understand the concept of risk-adjusted return before you start trading. The most common way to measure the risk of MiMedx is by using the Sharpe ratio. The ratio expresses how much excess return you acquire for the extra volatility you endure for holding a more risker asset than MiMedx. The Sharpe ratio is calculated by using standard deviation and excess return to determine reward per unit of risk. To understand how volatile MiMedx Group is, you must compare it to a benchmark. Traditionally, the risk-free rate of return is the rate of return on the shortest-dated U.S. Treasury, such as a 3-year bond.
When determining whether MiMedx Group is a strong investment it is important to analyze MiMedx's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact MiMedx's future performance. For an informed investment choice regarding MiMedx Stock, refer to the following important reports: Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in MiMedx Group. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in interest. You can also try the Portfolio File Import module to quickly import all of your third-party portfolios from your local drive in csv format.
Complementary Tools for MiMedx Stock analysis
When running MiMedx's price analysis, check to measure MiMedx's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy MiMedx is operating at the current time. Most of MiMedx's value examination focuses on studying past and present price action to predict the probability of MiMedx's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move MiMedx's price. Additionally, you may evaluate how the addition of MiMedx to your portfolios can decrease your overall portfolio volatility.
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk |
Is MiMedx's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of MiMedx. If investors know MiMedx will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about MiMedx listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 4 | Earnings Share 0.43 | Revenue Per Share 2.76 | Quarterly Revenue Growth 0.167 | Return On Assets 0.113 |
The market value of MiMedx Group is measured differently than its book value, which is the value of MiMedx that is recorded on the company's balance sheet. Investors also form their own opinion of MiMedx's value that differs from its market value or its book value, called intrinsic value, which is MiMedx's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because MiMedx's market value can be influenced by many factors that don't directly affect MiMedx's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between MiMedx's value and its price as these two are different measures arrived at by different means. Investors typically determine if MiMedx is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, MiMedx's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.